Evidence map›Paper›PMID 18074025›Full record

ArticlePloS one2007

Revisiting estimates of CTL killing rates in vivo.

Andrew Yates, Frederik Graw, Daniel L Barber, Rafi Ahmed, Roland R Regoes, Rustom Antia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Kill: boosting HIV-specific immune responses.Current opinion in HIV and AIDS · 2016
    Review
  8. Article
  9. How is the effectiveness of immune surveillance impacted by the spatial distribution of spreading infections?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Viral proteome size and CD8+ T cell epitope density are correlated: the effect of complexity on selection.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Andrew YatesDepartment of Biology, Emory University, Atlanta, Georgia, United States of America. ayates2@emory.edu
Frederik Graw
Daniel L Barber
Rafi Ahmed
Roland R Regoes
Rustom Antia
Emory University · USBoard of the Swiss Federal Institutes of Technology · CHETH Zurich · CHNational Institute of Allergy and Infectious Diseases · US

Funding

Quantititive models of CD8+ immune memoryR01AI049334 · NIAID · EMORY UNIVERSITY · PI ANTIA, RUSTOM NOSHIR · 2001 to 2011
$1.6M
NIAID NIH HHS R01 AI049334NIAID NIH HHS R01 AI 49334
6 · The paper itself

Abstract

Recent experimental advances have allowed the estimation of the in vivo rates of killing of infected target cells by cytotoxic T lymphocytes (CTL). We present several refinements to a method applied previously to quantify killing of targets in the spleen using a dynamical model. We reanalyse data previously used to estimate killing rates of CTL specific for two epitopes of lymphocytic choriomeningitis virus (LCMV) in mice and show that, contrary to previous estimates the "killing rate" of effector CTL is approximately twice that of memory CTL. Further, our method allows the fits to be visualized, and reveals one potentially interesting discrepancy between fits and data. We discuss extensions to the basic CTL killing model to explain this discrepancy and propose experimental tests to distinguish between them.

Indexed as

AnimalsEpitopesLymphocytic choriomeningitis virusMiceModels, BiologicalT-Lymphocytes, CytotoxicEpitopes

Identifiers

PMID18074025
PMCPMC2111049
OpenAlexW2005374621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.